Outset Medical
113 hedge funds and large institutions have $112M invested in Outset Medical in 2024 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 34 increasing their positions, 41 reducing their positions, and 34 closing their positions.
58% more call options, than puts
Call options by funds: $575K | Put options by funds: $363K
5.62% less ownership
Funds ownership: 105.58% → 99.95% (-5.6%)
17% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 41
19% less funds holding
Funds holding: 139 → 113 (-26)
40% less capital inflows, than outflows
Capital inflows: $27M | Capital outflows: $44.7M
74% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 34
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$7.19M |
| 2 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$4.19M |
| 3 |
D.E. Shaw & Co
New York
|
+$2.88M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.07M |
| 5 |
Millennium Management
New York
|
+$1.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$17.1M |
| 2 |
JP Morgan Chase
New York
|
-$6.23M |
| 3 |
Bellevue Group
Kuesnacht,
Switzerland
|
-$4.01M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.54M |
| 5 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$2.97M |
OM Hedge Fund Activity: Q1 2024 in Review
113 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q1 2024, worth a combined $112M — down 61% from $287M a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of OM and 9 opened new positions — a net loss of 25 holders — while 41 trimmed existing stakes and 34 added.
The largest buyer was Ameriprise, adding an estimated $7.19M. The largest seller was T. Rowe Price Investment Management, exiting entirely with an estimated $17.1M sold.
- 113 institutional investors held Outset Medical (OM) as of Q1 2024, down from 139 in Q4 2023.
- Funds reported $112M of Outset Medical stock for Q1 2024, down 61% quarter-over-quarter.
- 9 funds opened new Outset Medical positions in Q1 2024 and 34 closed out, a net change of -25 holders.
- The largest Outset Medical buyer in Q1 2024 was Ameriprise, an estimated $7.19M added.
- The largest Outset Medical seller in Q1 2024 was T. Rowe Price Investment Management, an estimated $17.1M sold.
Based on aggregated 13F filings for Q1 2024.